利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

8 条记录 (耗时 0.009 秒)

    Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1H-3-indazolecarboxylic acid amides
    1.
    发明授权
    Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1H-3-indazolecarboxylic acid amides 有权
    在双环5-（三氟甲氧基）-1H-3-吲哚羧酸酰胺的合成中制备吲唑中间体的无重氮方法

    公开(公告)号：US08232412B2

    公开(公告)日：2012-07-31

    申请号：US12576259

    申请日：2009-10-09

    申请人： Thomas Cleary ,  Yaohui Ji ,  Thimma Rawalpally

    发明人： Thomas Cleary ,  Yaohui Ji ,  Thimma Rawalpally

    IPC分类号： C07D231/56 ,  C07D231/54

    CPC分类号： C07D453/02 ,  C07D231/56

    摘要： The present invention provides novel methods for preparing 5-(trifluoromethoxy)-1H-3-indazolecarboxylic acid (3), which is a useful precursor for the preparation of bicyclic-5-trifluoromethoxy-1H-indazole-3-carboxylic acid amides of Formula (1). Compounds of Formula (1) are active as agonists and partial agonists of the nicotinic α-7 receptor and are being studied for their use in the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain, such as for the treatment of Alzheimer's disease and schizophrenia, as well as other psychiatric and neurological disorders. The present methods are useful for preparing compound (3) on scale up levels.

    摘要翻译： 本发明提供了制备5-（三氟甲氧基）-1H-3-吲哚羧酸（3）的新方法，其是制备式（I）的双环-5-三氟甲氧基-1H-吲唑-3-羧酸酰胺的有用前体 （1）。 式（1）的化合物作为烟酸α-7受体的激动剂和部分激动剂是有活性的，并且正在研究用于治疗与缺陷或功能异常的烟碱乙酰胆碱受体（特别是脑）有关的疾病状况，例如 治疗阿尔茨海默病和精神分裂症，以及其他精神和神经障碍。 本发明的方法可用于按比例制备化合物（3）。

    DIAZONIUM-FREE METHOD TO MAKE AN INDAZOLE INTERMEDIATE IN THE SYNTHESIS OF BICYCLIC 5-(TRIFLUORMETHOXY)-1H-3-INDAZOLECARBOXYLIC ACID AMIDES
    4.
    发明申请
    DIAZONIUM-FREE METHOD TO MAKE AN INDAZOLE INTERMEDIATE IN THE SYNTHESIS OF BICYCLIC 5-(TRIFLUORMETHOXY)-1H-3-INDAZOLECARBOXYLIC ACID AMIDES 有权
    在双酚-5-（三氟甲基）-1H-3-异吲哚酸酰胺的合成中制备吲哚中间体的无氮方法

    公开(公告)号：US20120259120A1

    公开(公告)日：2012-10-11

    申请号：US13528894

    申请日：2012-06-21

    申请人： Thomas Cleary ,  Yaohui Ji ,  Thimma Rawalpally

    发明人： Thomas Cleary ,  Yaohui Ji ,  Thimma Rawalpally

    IPC分类号： C07D231/56 ,  C07D453/02

    CPC分类号： C07D453/02 ,  C07D231/56

    摘要： The present invention provides novel methods for preparing 5-(trifluoromethoxy)-1H-3-indazolecarboxylic acid (3), which is a useful precursor for the preparation of bicyclic-5-trifluoromethoxy-1H-indazole-3-carboxylic acid amides of Formula (1). Compounds of Formula (1) are active as agonists and partial agonists of the nicotinic α-7 receptor and are being studied for their use in the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain, such as for the treatment of Alzheimer's disease and schizophrenia, as well as other psychiatric and neurological disorders. The present methods are useful for preparing compound (3) on scale up levels.

    摘要翻译： 本发明提供了制备5-（三氟甲氧基）-1H-3-吲哚羧酸（3）的新方法，其是制备式（I）的双环-5-三氟甲氧基-1H-吲唑-3-羧酸酰胺的有用前体 （1）。 式（1）的化合物作为烟酸α-7受体的激动剂和部分激动剂是有活性的，并且正在研究用于治疗与缺陷或功能异常的烟碱乙酰胆碱受体（特别是脑）有关的疾病状况，例如 治疗阿尔茨海默病和精神分裂症，以及其他精神和神经障碍。 本发明的方法可用于按比例制备化合物（3）。

    Methods for stabilizing lithiated halogen-substituted aromatic compounds
    5.
    发明授权
    Methods for stabilizing lithiated halogen-substituted aromatic compounds 失效
    稳定锂化卤素取代芳香族化合物的方法

    公开(公告)号：US07619123B2

    公开(公告)日：2009-11-17

    申请号：US12257419

    申请日：2008-10-24

    申请人： Yaohui Ji ,  Thimma Rawalpally

    发明人： Yaohui Ji ,  Thimma Rawalpally

    IPC分类号： C07C45/00

    CPC分类号： C07C45/00 ,  C07C47/55 ,  C07C47/575

    摘要： The present invention provides novel methods for stabilizing lithiated halogen-substituted aromatic compounds. In particular, the method is useful for the preparation of 2-methoxy-5,6-difluorobenzaldehyde, an important intermediate for the preparation of [4-amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6methoxyphenyl)methanone, a potent and selective inhibitor of CDK4/Cyclin D1, CDK2/Cyclin E and CDK1/Cyclin B. The method is also useful for stabilizing other lithiated halogen-substituted aromatic compounds and is particularly useful for scale up reactions where the exothermic nature of the reaction can lead to reaction runway.

    摘要翻译： 本发明提供了稳定锂化卤素取代的芳族化合物的新方法。 特别地，该方法可用于制备2-甲氧基-5,6-二氟苯甲醛，其是制备[4-氨基-2-（1-甲磺酰基哌啶-4-基氨基）嘧啶-5-基] （2,3-二氟-6-甲氧基苯基）甲酮，一种有效和选择性的CDK4 /细胞周期蛋白D1，CDK2 /细胞周期蛋白E和CDK1 /细胞周期蛋白B抑制剂。该方法也可用于稳定其他锂化卤素取代的芳族化合物，特别有用 用于放大反应，其中反应的放热性质可导致反应跑道。

    DIAZONIUM-FREE METHOD TO MAKE AN INDAZOLE INTERMEDIATE IN THE SYNTHESIS OF BICYCLIC 5-(TRIFLUORMETHOXY)-1H-3-INDAZOLECARBOXYLIC ACID AMIDES
    6.
    发明申请
    DIAZONIUM-FREE METHOD TO MAKE AN INDAZOLE INTERMEDIATE IN THE SYNTHESIS OF BICYCLIC 5-(TRIFLUORMETHOXY)-1H-3-INDAZOLECARBOXYLIC ACID AMIDES 有权
    在双酚-5-（三氟甲基）-1H-3-异吲哚酸酰胺的合成中制备吲哚中间体的无氮方法

    公开(公告)号：US20100094011A1

    公开(公告)日：2010-04-15

    申请号：US12576259

    申请日：2009-10-09

    申请人： Thomas Cleary ,  Yaohui Ji ,  Thimma Rawalpally

    发明人： Thomas Cleary ,  Yaohui Ji ,  Thimma Rawalpally

    IPC分类号： C07D221/22 ,  C07D231/56

    CPC分类号： C07D453/02 ,  C07D231/56

    摘要： The present invention provides novel methods for preparing 5-(trifluoromethoxy)-1H-3-indazolecarboxylic acid (3), which is a useful precursor for the preparation of bicyclic-5-trifluoromethoxy-1H-indazole-3-carboxylic acid amides of Formula (1). Compounds of Formula (1) are active as agonists and partial agonists of the nicotinic α-7 receptor and are being studied for their use in the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain, such as for the treatment of Alzheimer's disease and schizophrenia, as well as other psychiatric and neurological disorders. The present methods are useful for preparing compound (3) on scale up levels.

    摘要翻译： 本发明提供了制备5-（三氟甲氧基）-1H-3-吲哚羧酸（3）的新方法，其是制备式（I）的双环-5-三氟甲氧基-1H-吲唑-3-羧酸酰胺的有用前体 （1）。 式（1）的化合物作为烟酸α-7受体的激动剂和部分激动剂是有活性的，并且正在研究用于治疗与缺陷或功能异常的烟碱乙酰胆碱受体（特别是脑）有关的疾病状况，例如 治疗阿尔茨海默病和精神分裂症，以及其他精神和神经障碍。 本发明的方法可用于按比例制备化合物（3）。

    Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1H-3-indazolecarboxylic acid amides
    7.
    发明授权
    Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1H-3-indazolecarboxylic acid amides 有权
    在双环5-（三氟甲氧基）-1H-3-吲哚羧酸酰胺的合成中制备吲唑中间体的无重氮方法

    公开(公告)号：US08354536B2

    公开(公告)日：2013-01-15

    申请号：US13528894

    申请日：2012-06-21

    申请人： Thomas Cleary ,  Yaohui Ji ,  Thimma Rawalpally

    发明人： Thomas Cleary ,  Yaohui Ji ,  Thimma Rawalpally

    IPC分类号： C07D453/02 ,  C07D241/38

    CPC分类号： C07D453/02 ,  C07D231/56

    摘要： The present invention provides novel methods for preparing 5-(trifluoromethoxy)-1H-3-indazolecarboxylic acid (3), which is a useful precursor for the preparation of bicyclic-5-trifluoromethoxy-1H-indazole-3-carboxylic acid amides of Formula (1). Compounds of Formula (1) are active as agonists and partial agonists of the nicotinic α-7 receptor and are being studied for their use in the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain, such as for the treatment of Alzheimer's disease and schizophrenia, as well as other psychiatric and neurological disorders. The present methods are useful for preparing compound (3) on scale up levels.

    摘要翻译： 本发明提供了制备5-（三氟甲氧基）-1H-3-吲哚羧酸（3）的新方法，其是制备式（I）的双环-5-三氟甲氧基-1H-吲唑-3-羧酸酰胺的有用前体 （1）。 式（1）的化合物作为烟酸α-7受体的激动剂和部分激动剂是有活性的，并且正在研究用于治疗与缺陷或功能异常的烟碱乙酰胆碱受体（特别是脑）有关的疾病状况，例如 治疗阿尔茨海默病和精神分裂症，以及其他精神和神经障碍。 本发明的方法可用于按比例制备化合物（3）。

    METHODS FOR STABILIZING LITHIATED HALOGEN-SUBSTITUTED AROMATIC COMPOUNDS
    8.
    发明申请
    METHODS FOR STABILIZING LITHIATED HALOGEN-SUBSTITUTED AROMATIC COMPOUNDS 失效
    用于稳定取代的取代的芳族化合物的方法

    公开(公告)号：US20090118546A1

    公开(公告)日：2009-05-07

    申请号：US12257419

    申请日：2008-10-24

    申请人： Yaohui Ji ,  Thimma Rawalpally

    发明人： Yaohui Ji ,  Thimma Rawalpally

    IPC分类号： C07C45/00

    CPC分类号： C07C45/00 ,  C07C47/55 ,  C07C47/575

    摘要： The present invention provides novel methods for stabilizing lithiated halogen-substituted aromatic compounds. In particular, the method is useful for the preparation of 2-methoxy-5, 6-difluorobenzaldehyde, an important intermediate for the preparation of [4-amino-2-(1-methanesulfonylpiperidin-4-ylamino) pyrimidin-5-yl](2,3-difluoro-6methoxyphenyl)methanone, a potent and selective inhibitor of CDK4/Cyclin D1, CDK2/Cyclin E and CDK1/Cyclin B. The method is also useful for stabilizing other lithiated halogen-substituted aromatic compounds and is particularly useful for scale up reactions where the exothermic nature of the reaction can lead to reaction runway.

    摘要翻译： 本发明提供了稳定锂化卤素取代的芳族化合物的新方法。 特别地，该方法可用于制备2-甲氧基-5,6-二氟苯甲醛，其是制备[4-氨基-2-（1-甲磺酰基哌啶-4-基氨基）嘧啶-5-基] （2,3-二氟-6-甲氧基苯基）甲酮，一种有效和选择性的CDK4 /细胞周期蛋白D1，CDK2 /细胞周期蛋白E和CDK1 /细胞周期蛋白B抑制剂。该方法也可用于稳定其他锂化卤素取代的芳族化合物，特别有用 用于放大反应，其中反应的放热性质可导致反应跑道。